Thomas Schinecker to become Roche CEO

Wednesday 27 July 2022
Roche Group
Appointee name
Thomas Schinecker


Thomas Schinecker has been named chief executive designate of the Roche Group, effective 15 March 2023, succeeding Severin Schwan who is to be nominated as chairman of the board of directors. The change in leadership at one of Europe’s largest pharmaceutical companies, was announced on 21 July 2022. Dr Schwan has been the Roche CEO since 2008.

Dr Schinecker is currently chief executive of the company’s diagnostic division. He holds a PhD in molecular biology and has been working for Roche in different executive positions since 2003. He became head of the diagnostics division and a member of the corporate executive committee in August 2019.

Copyright 2022 Evernow Publishing Ltd